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Schistosomiasis is a tropical disease affecting over 230 million people worldwide. Although effective drug treatment is available,
reinfections are common, and development of immunity is slow. Most antibodies raised during schistosome infection are di-
rected against glycans, some of which are thought to be protective. Developing schistosomula are considered most vulnerable to
immune attack, and better understanding of local antibody responses raised against glycans expressed by this life stage might
reveal possible glycan vaccine candidates for future vaccine research. We used antibody-secreting cell (ASC) probes to character-
ize local antiglycan antibody responses against migrating Schistosoma japonicum schistosomula in different tissues of rats.
Analysis by shotgun Schistosoma glycanmicroarray resulted in the identification of antiglycan antibody response patterns that
reflected the migratory pathway of schistosomula. Antibodies raised by skin lymph node (LN) ASC probes mainly targeted N-
glycans with terminal mannose residues, Gal1-4GlcNAc (LacNAc) and Gal1-4(Fuc1-3)GlcNAc (LeX). Also, responses to an-
tigenic and schistosome-specific glycosphingolipid (GSL) glycans containing highly fucosylated GalNAc1-4(GlcNAc1)n
stretches that are believed to be present at the parasite’s surface constitutively upon transformation were found. Antibody tar-
gets recognized by lung LN ASC probes were mainly N-glycans presenting GalNAc1-4GlcNAc (LDN) and GlcNAcmotifs. Sur-
prisingly, antibodies against highly antigenic multifucosylated motifs of GSL glycans were not observed in lung LN ASC probes,
indicating that these antigens are not expressed in lung stage schistosomula or are not appropriately exposed to induce immune
responses locally. The local antiglycan responses observed in this study highlight the stage- and tissue-specific expression of anti-
genic parasite glycans and provide insights into glycan targets possibly involved in resistance to S. japonicum infection.
Schistosomiasis is one of the neglected tropical diseases with thehighest impacts on human health. Over 230 million people are
infected worldwide, and over 500 million are at risk of infection
(1–3). Infection leads to chronic disease characterized by pro-
nounced immunological reactions against eggs deposited into
host tissues by the adult schistosome worms, which eventually
lead to fibrosis and organ failure (2). Although effective treatment
is available, reinfection occurs rapidly and immunity develops
only slowly, stressing the need for a prophylactic vaccine as part of
a sustainable control strategy (4–6).
Schistosomes have a complex life cycle with different life stages
that interact with the human host and that each play a role in
immunology, immunopathology, and maintenance of infection.
Schistosoma infection occurs after direct contact with water con-
taining the larval form of the parasite (cercariae). Cercariae pen-
etrate the host skin and transform into schistosomula, which enter
the vasculature and mature while migrating via the lungs to the
portal veins. When fully developed, male and female worms pair
and, in the cases of Schistosoma japonicum and Schistosoma man-
soni, migrate to the mesenteric venous plexus, where the female
worms start producing eggs. Adult worm pairs can survive for
several years, producing hundreds of eggs per day, unless the in-
fection is treated by chemotherapy. The specific locations of the
different life stages of the schistosome lead to unique interactions
with different parts of the host immune system (2, 7). At the mo-
lecular level, the expression of proteins and glycans is develop-
mentally regulated and subject to constant change during schisto-
some development (8, 9). This specific antigen expression by
different developmental stages could be a strategy to escape the
host’s immune system, but it may also lead to specific local pro-
tective immune responses of the host (10).
Schistosomula, the migratory larvae, are probably the most
important targets of immunity. Effective elimination of these life
stages would prevent the establishment of infection, thereby pre-
venting egg-induced pathology and transmission of the disease. It
has been shown in vitro that schistosomula can be targets of effec-
tive antibody-mediated immune responses and that secondary in-
fection in the laboratory rat is a good model of this humoral im-
munity (11, 12). IgG1, IgG2, and IgG3 have been associated with
killing of schistosomula through an antibody-dependent cellular
cytotoxic process mediated by activated, as well as nonactivated,
eosinophils (13). IgG2 has a dual function, as it has cytotoxic
activity in the presence of activated eosinophils, while in the pres-
ence of nonactivated eosinophils it was able to block protective
responses. IgG4 has no cytotoxic activity and can block the effects
of IgG1, IgG2, and IgG3 (13). Furthermore, other studies have
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indicated a role for IgE and IgA in the elimination of schistoso-
mula through similar mechanisms (14, 15).
Like all other schistosome life stages, schistosomula are abun-
dantly glycosylated. Since schistosome glycans have repeatedly
been described as major targets of antibody responses (16–18),
they could play a role in the induction of immunity. Over the past
several decades, glycans expressed during schistosome development
have been characterized (9, 19–27). Overall, the glycans of schistoso-
mula up to 3 days old were similar to those present in cercariae (9,
20–22, 24, 26, 27). N-glycans feature oligomannosyl structures,
Gal1-4GlcNAc (LacNAc) and Gal1-4(Fuc1-3)GlcNAc (Lewis X,
or LeX) antennae, and core xylosylation, while glycosphingolipid
(GSL) glycans are mainly presented with terminal LeX, Fuc1-
3Gal1-4(Fuc1-3)GlcNAc (pseudo-Lewis Y, or pseudo-LeY), and
multifucosylated GalNAc1-4GlcNAc (LacDiNAc, or LDN) motifs.
O-glycans displaying partly similar motifs were abundantly present in
cercariae, but they gradually disappeared in the developing schisto-
somula (9). In contrast, N-glycan expression remained during
further development of schistosomula, although the N-glycan
profile showed a gradual change toward oligomannosyl glycans
and complex-type structures, which predominantly expressed
LDN antennae without core xyloses, similar to the adult worm (9,
20–22, 24, 26, 27). The overall GSL glycan expression remained
largely unchanged after transformation and early schistosomula
development (9). Nonetheless, regardless of these overall expres-
sion patterns, clear changes in the surface-exposed glycan antigens
of early schistosome larvae were observed in studies using antig-
lycan monoclonal antibodies and immunofluorescence micros-
copy. Mono- and multifucosylated LDN motifs, except LDN-F,
present on O- or GSL glycans, were present at the surface before
and after transformation, whereas glycans carrying LeX and
LDN-F motifs appeared at the surface for the first time shortly
after transformation (28). Such glycans exposed on the surfaces of
the vulnerable schistosomula may form the targets of antibody-
mediated immunity against infection with schistosomes.
To study local antibody responses to glycans of migrating
schistosomula, we used the antibody-secreting cell (ASC) probe
method in rats upon secondary infection with S. japonicum (29,
30). Rats are semipermissive hosts for schistosomes, as they be-
come infected by cercariae but the parasite does not complete its
life cycle. The initial course of infection is normal, but rats are
capable of a self-cure mechanism resulting in a drop in parasite
burden between 3 and 4 weeks after initial infection. Also, immu-
nity to reinfection is developed, and reinfections are rapidly elim-
inated, mainly before or during passage through the lung vascu-
lature. These protective responses are antibody mediated and
resemble the type 2 response seen in humans (31, 32). Therefore,
the rat is a good model to study protective immune responses.
Using this method, it was shown previously that migrating S. ja-
ponicum schistosomula in rats induced antibodies in the lung to
several high-molecular-weight protein antigens of larvae and
worms, as well as antibodies to synthetic glycan elements, includ-
ing GlcNAc, LeX, and LacNAc and fucosylated N-glycan core
structures (10, 33). While the use of these nonspecific synthetic
glycans provided insights into the potential importance of antig-
lycan antibodies, the naturally occurring glycans on the surfaces
and in secretions of schistosomula are far more complex than the
glycans previously studied and often carry glycan motifs unique to
the schistosome. In the current study, therefore, we analyzed ASC
probe samples derived from lungs of S. japonicum-infected rats
using shotgun glycan microarrays of naturally occurring glycans
isolated from several schistosome life stages. In addition, we in-
cluded skin ASC probes to study antiglycan responses that are
induced early upon transformation into schistosomula. We show
that N-glycans expressing terminal GlcNAc, LDN, LeX, and LacNAc
motifs and oligomannosyl glycans and GSL glycans expressing
unique highly fucosylated GalNAc1-4(GlcNAc 1)n stretches were
the major targets of antibodies raised in the skin of infected rats,
whereas antibodies raised in the lung tissue were predominantly
directed against N-glycans expressing nonfucosylated LDN and
terminal GlcNAc motifs. These observations indicate which gly-
can structures might be involved in antibody-mediated protection
against S. japonicum in rats.
MATERIALS AND METHODS
ASC probes. ASC probes were produced as described previously (10). In
short, a Chinese strain of Oncomelania hupensis snails (Anhui Province,
People’s Republic of China) was used to obtain S. japonicum cercariae,
which were subsequently used for the infection of female Wistar rats. The
rats were infected percutaneously with 125 (primary infection) and 350
(secondary infection, 6 weeks after primary infection) cercariae. Axillary
and inguinal lymph nodes (LN) (skin LN) and mediastinal LN (lung LN)
were isolated from an uninfected control group and from two groups of
rats at 5 and 9 days after secondary infection, respectively. The timing of
the isolation of LN corresponded to the expected peak in antibody pro-
duction in the skin (5 days postinfection) and lung (9 days postinfection)
LN (10). The LN were dissected, and cell suspensions were made and
cultured at 37°C and 5% CO2 for 5 days. Supernatants containing anti-
bodies secreted by in vivo-induced ASCs (ASC probes) were then collected
and used for incubation on glycan microarrays.
Glycan microarray development. In previous studies, the develop-
ment of glycan arrays has been described extensively (34, 35). Briefly,
N-glycans, O-glycans, and GSL glycans were obtained from cercariae,
adult worms, and eggs from a Puerto Rican strain of S. mansoni. 2-Ami-
nobenzoic acid (2-AA)-derivatized glycans were fractionated in two di-
mensions by hydrophilic interaction liquid chromatography (HILIC)-
and reversed-phase liquid chromatography (RP-LC), and the collected
glycan-containing fractions were subsequently printed in triplicate to ep-
oxysilane-coated glass slides, together with synthetic glycoconjugates.
Three individual arrays were printed to each glass slide, each array con-
taining a total of 888 LC fractions (127 from cercarial N-glycans, 115 from
adult worm N-glycans, 110 from egg N-glycans, 37 from cercarial GSL
glycans, 66 from egg GSL glycans, 137 from cercarial O-glycans, 79 from
adult worm O-glycans, 146 from egg O-glycans, and 71 from synthetic
glycoconjugates and proteins).
Glycan microarray analysis. Glycan microarray slides were covered
with hand-cut silicone gaskets to create barriers between individual ar-
rays. Prior to use, any remaining reactive epoxysilane groups were blocked
for 60 min at room temperature with phosphate-buffered saline (PBS)
containing 2% bovine serum albumin (BSA) and 50 mM ethanolamine.
Then, the slides were rinsed with PBS and incubated with ASC probe
sample diluted 1:5 in PBS-0.01% Tween 20 with 1% BSA for 60 min at
room temperature. The slides were subsequently rinsed with PBS-0.05%
Tween 20 and PBS, followed by incubation for 30 min at room tempera-
ture with Alexa Fluor 555-labeled goat anti-rat IgG and Alexa Fluor 647-
labeled goat anti-rat IgM, both diluted 1:1,000 in PBS-0.01% Tween 20
with 1% BSA. Then, the slides were flushed with PBS-0.05% Tween 20,
PBS, and Milli-Q. After drying by centrifugation, the slides were stored in
the dark before scanning. Scanning was performed using a G2565BA scan-
ner (Agilent Technologies, Santa Clara, CA) at 10-m resolution with 2
lasers (532 nm and 633 nm). The scanned images were analyzed with
Genepix Pro 7.0 software. Spots were aligned and resized using round
features and no composite pixel intensity (CPI) threshold. The median
fluorescence intensities of each of the spots with background subtracted
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were then averaged for each glycan sample. The data sets were log2 trans-
formed to remove the basic trends of variance.
Response patterns and statistics. LC fractions showing significant
differences in signal intensities for the different ASC probes were identi-
fied using analysis of variance (ANOVA) (P  0.05) and were grouped
based on response patterns using hierarchical-clustering analysis (HCA)
(complete linkage clustering using Euclidean distance). Branches with
approximately the same horizontal distribution and strongest/largest dis-
tance between clusters were used to classify the most discriminative clus-
ters.
Mass spectrometry and structural assignments. LC fractions were
analyzed by matrix-assisted laser desorption ionization–time of flight
mass spectrometry (MALDI-TOF MS) using Ultraflex II and Ultraflex-
treme mass spectrometers (Bruker Daltonics, Bremen, Germany) in neg-
ative-ion reflectron mode with 2,5-dihydroxybenzoic acid (DHB)
(Bruker Daltonics) as the matrix. The detected masses were translated
into putative glycan structures using Glycopeakfinder (http://glyco
-peakfinder.org), the literature (9, 19–27, 36–41), and our own unpub-
lished tandem-MS (MS-MS) data. The three most abundant signals in
each mass spectrum were translated into glycan structures, unless the
individual signals made up less than 10% of the total intensity of all glycan
masses in the spectrum of a glycan sample.
RESULTS
To study the local antibody responses to schistosome glycans, we
used ASC probes isolated from rats with a secondary S. japonicum
infection and compared the binding of antibodies generated in
skin and lung LN using shotgun glycan microarrays. These LN and
the timing of their isolation at 5 (I5) and 9 (I9) days after secondary
infection reflected the migratory pathway of invading schistosome
larvae and corresponded to the expected peak in antibody produc-
tion in the skin and lungs, respectively. Glycan LC fractions show-
ing significant differences in antibody binding between controls
(C), I5, and I9 were clustered according to the antibody response
patterns raised against the antigenic glycan motifs present in these
LC fractions in a specific LN over time. Glycan-binding patterns
were defined for IgG, as well as IgM, in the skin and lung LN ASC
probes.
Skin LNASCprobe IgG. For the skin LN ASC probes, a total of
101 LC fractions, synthetic glycoconjugates, and glycoprotein
mixtures/isolates showed differential IgG binding that could be
grouped in three major glycan clusters (Fig. 1A) with different
response patterns (Fig. 1C). Glycan cluster skin-IgG-C1 showed a
rise in signal intensity for group I5 compared to the control rats,
which remained equally high or slightly increased for group I9. A
total of 18 LC fractions were found within this cluster and con-
tained mainly N- and GSL glycans derived from cercariae and eggs
(Fig. 1E). N-glycans present within these LC fractions showed
numerous different terminal glycan motifs, including GlcNAc
(egg N-glycan fractions 28 and 30), LDN (worm N-glycan fraction
16.4 and egg N-glycan fraction 28), LacNAc (cercarial N-glycan
fraction 22, worm N-glycan fraction 16.4, and egg N-glycan frac-
tions 28 and 30), and LeX (cercarial N-glycan fractions 26, 27, and
34 and worm N-glycan fraction 16.4). Also, mannosyl glycans
were targeted (cercarial N-glycan fraction 22 and egg N-glycan
fractions 14 and 30) (Table 1). Other N-glycan motifs recognized
by antibodies in the skin LN ASC probes within this cluster were
GalNAc1-4(Fuc1-3)GlcNAc1 (LDN-F) (worm N-glycan
fraction 16.4) and F-GlcNAc (cercarial N-glycan fraction 34) (Ta-
ble 1). Furthermore, numerous GSL glycan fractions present
within glycan cluster skin-IgG-C1 were characterized by the pres-
ence of highly fucosylated GalNAc1-4(GlcNAc 1)n stretches
(cercarial GSL glycan fractions 19, 21, and 25 and egg GSL glycan
fractions 22.1, 23.1, 24.1, 25.2, and 26.1) (Table 1).
Glycan cluster skin-IgG-C2 also showed a rise in antibody sig-
nal intensities for group I5 compared to the control rats, which
remained equally high or slightly increased for group I9; however,
signal intensities were lower than for cluster skin-IgG-C1 (Fig.
1C). Cluster skin-IgG-C2 contained 39 LC fractions, synthetic gly-
coconjugates, and glycoprotein mixtures/isolates, the majority of
which (around 50%) were N-glycans derived from different life
stages, including cercariae, worms, and eggs (Fig. 1E). This spe-
cific set of N-glycans was characterized by the presence of a wide
variety of terminal motifs, which we observed for cluster skin-
IgG-C1, as well. The most abundant terminal motifs within cluster
skin-IgG-C2 were GlcNAc (cercarial N-glycan fractions 18, 28.6,
and 37; worm N-glycan fraction 9; and egg N-glycan fractions 15,
20, and 27), LDN (worm N-glycan fractions 9, 12.6, and 15 and
egg N-glycan fractions 29 and 39.2), LacNAc (cercarial N-glycan
fractions 24.6, 28.6, and 37 and egg N-glycan fractions 27 and 29),
LeX (cercarial N-glycan fractions 27.6, 28.6, and 37 and egg N-gly-
can fraction 39.2), and mannosyl (cercarial N-glycan fractions 25,
27.6, and 37; worm N-glycan fractions 6.3 and 9; and egg N-glycan
fractions 13, 15, 17, 20, 27, and 29) residues (Table 1). Terminal
motifs less frequently found within these N-glycans than in cluster
skin-IgG-C1 included LDN-F (cercarial N-glycan fraction 25) and
GalNAc1-4(Fuc1-2Fuc1-3)GlcNA1- (LDN-DF) (egg N-gly-
can fraction 39.2) (Table 1). In contrast to skin IgG cluster C1, GSL
glycans bearing highly fucosylated GalNAc1-4(GlcNAc1)n
stretches were absent in cluster skin-IgG-C2. Other LC fractions
found within skin IgG cluster C2 contained GSL glycans derived
from cercariae, displaying either LDN (cercarial GSL glycan frac-
tion 32), LeX (cercarial GSL glycan fraction 17), or pseudo-LeY
(cercarial GSL glycan fraction 27) motifs (Table 1). One LC frac-
tion with cercarial O-glycans presenting Fuc1-2Fuc1-3 (DF)
motifs attached to terminal GlcNAc, as well as internal LDN mo-
tifs (cercarial O-glycan fraction 16.6), was also found within this
cluster (Table 1). Binding of the ASC probe antibodies to synthetic
glycoconjugates related to these motifs was in line with these ob-
servations (Table 1). Since the antibody responses within skin IgG
clusters C1 and C2 were induced in I5 and sustained in I9, it is likely
that the glycan structures identified within these clusters are asso-
ciated with the migrating schistosomula or with schistosomulum-
or cercaria-derived material that is left behind in the skin, e.g.,
secreted glycoproteins, fragments of the glycocalyx, or dying
schistosomula.
Glycan cluster skin-IgG-C3 showed no change in signal inten-
sity for group I5 compared to the control group, but signal inten-
sities increased in group I9 (Fig. 1C). This cluster contained 12 LC
fractions, half of which were cercaria-derived N-glycans (Fig. 1E).
These N-glycans again contained terminal GlcNAc (cercarial N-
glycan fraction 24), LacNAc (cercarial N-glycan fractions 24 and
29), and LeX (cercarial N-glycan fraction 29) motifs, as well as
mannosyl termini (cercarial N-glycan fractions 11 and 13) (Table
1). Worm-derived O-glycans found within this cluster also con-
tained LeX and LacNAc motifs (worm O-glycan fraction 15.5).
Also, a specific GSL glycan sample (egg GSL glycan fraction HF
9.3) with terminal LDN was observed in this response pattern.
Antibody responses to these glycan motifs in this specific context
thus seem to be induced after the schistosomula have already left
the skin tissue and migrated toward the lungs, suggesting that
Local Antiglycan Responses to Migratory Schistosomula
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these antibodies are triggered by schistosomulum- or cercaria-
derived material trapped in the skin.
Most notably, these different response patterns show that
highly fucosylated GalNAc1-4(GlcNAc1)n stretches on GSL
glycans were identified only in cluster skin-IgG-C1, which already
displayed the largest increases in IgG signal intensities in group I5.
Furthermore, the IgG response patterns of the skin LN ASC
probes recognized mostly N- and GSL glycans, whereas O-glycans
were hardly recognized. Besides the highly fucosylated
GalNAc1-4(GlcNAc1)n stretches on GSL glycans, the N- and
GSL glycans recognized in the different response patterns carry
several other terminal motifs, including terminal mannose and
terminal GlcNAc, LeX, LacNAc, and LDN motifs. These motifs
could be found in all identified response patterns.
Lung LN ASC probe IgG. For the lung LN ASC probes, a total
of 20 LC fractions and glycoprotein isolates/mixtures showed dif-
ferential IgG binding, for which we observed three clusters (Fig.
1B) with different response patterns (Fig. 1D). Cluster lung-IgG-
C1, which showed a rise in antibody signal intensities for group I5
compared to the control rats and even higher signal intensities for
group I9 (Fig. 1D), contained only two glycoprotein isolates/mix-
tures from Schistosoma, making it impossible to define which mo-
tifs are bound (Fig. 1F). Cluster lung-IgG-C2 showed a response
pattern very similar to that of cluster lung IgG-C1, albeit with
much lower antibody signal intensities for all groups (Fig. 1D).
This cluster included 5 LC fractions that were all N-glycans de-
rived from cercariae, adult worms, and eggs (Fig. 1F). Structures
with terminal mannose residues were detected in most of the LC
fractions of this cluster (worm N-glycan fractions 2.1 and 8.5 and
egg N-glycan fraction 32.5) (Table 2). In addition, structures with
LeX (cercarial N-glycan fractions 27 and 32.7), LDN-DF (egg N-
glycan fraction 32.5), and terminal GlcNAc (cercarial N-glycan
fraction 32.7) were observed, as well (Table 2). It is worth noting
that these structures thus already give rise to antibodies in the lung
LN ASC probes very early upon contact with migrating schistoso-
mula, possibly because the time the migrating schistosomula re-
side in the skin varies and some schistosomula might have already
FIG 1 (A and B) Hierarchical-clustering analysis of log2-transformed median fluorescence intensities with classification of the antiglycan IgG responses in skin
LN (A) and lung LN (B) into three major clusters each. (C and D) Fluorescence intensity signals were averaged for each cluster and showed different response
profiles for skin LN IgG (C) and for lung LN IgG (D). (E and F) Distribution of glycan origins within each skin LN (E) and lung LN (F) glycan cluster. C,
(synthetic) glycoconjugates; N, N-glycan; O, O-glycan; L, GSL glycan.
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TABLE 1 Glycan fractions identified in the different clusters for IgG responses in the skin LN ASC probesa
(Continued on following page)
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a Putative structures and structural elements are proposed using literature-guided interpretations of the glycan compositions obtained by MALDI-TOF MS on the basis of
the references listed. C, cluster; fr., fraction; ref., references; Man, terminal mannose(s); core fuc, core fucosylation; core xyl, core xylosylation; X, xylose; F, fucose; H,
hexose; N, N-acetylhexosamine; dark square, N-acetylglucosamine (GlcNAc); light square, N-acetylgalactosamine; medium dark circle, mannose; dark circle, glucose; light
circle, galactose; dark triangle, fucose; white star, xylose; AA, AA label; LacNAc, Gal1-4GlcNAc1; LewisX, Gal1-4(Fuc1-3)GlcNAc1; LDN, GalNAc1-4GlcNAc1.
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migrated toward the lung tissue, where they could induce immu-
nological reactions (42, 43).
Cluster lung-IgG-C3 showed no change in signal intensity for
group I5 compared to the control group, but signal intensities
increased in group I9 (Fig. 1D), corresponding to the expected
peak in antibody production after the schistosomula reached the
lungs. This cluster contains 13 LC fractions, containing exclu-
sively N- and O-glycans derived from adult worms (Fig. 1F). Most
of the LC fractions detected in cluster lung-IgG-C3 contained N-
glycan structures with GlcNAc and LDN motifs (worm N-glycan
fractions 5.5, 8, 13.2, 13.3, 13.5, 13.8, and 16.7) (Table 2). A single
O-glycan structure presented terminal GlcNAc, as well (worm O-
glycan fraction 17) (Table 2). In contrast to the responses raised in
the skin, fucosylated variants of these motifs were not seen in the
response pattern. In addition to the LDN and GlcNAc motifs,
structures with terminal mannose residues were detected in mul-
tiple LC fractions (worm N-glycan fractions 13.3, 16.1, 17.3, and
19.4), while other structures displayed terminal LacNAc (worm
N-glycan fractions 13.2, 13.3, 13.5, and 16.7) and LeX (worm O-
glycan fractions 13 and 17) motifs.
Strikingly, multifucosylated GSL glycan structures, abundantly
expressed at the surfaces of lung stage schistosomula (28), were
not associated with any of the lung IgG response patterns. The
clearest targets of the IgG in the lung LN ASC probes are N-glycans
TABLE 2 Glycan fractions identified in the different clusters for the IgG responses in the lung LN ASC probesa
a Putative structures and structural elements are proposed using literature-guided interpretations of the glycan compositions obtained by MALDI-TOF MS on the basis of the
references listed. C, cluster; fr., fraction; ref., references; Man, terminal mannose(s); core fuc, core fucosylation; core xyl, core xylosylation; X, xylose; F, fucose; H, hexose; N, N-
acetylhexosamine; dark square, N-acetylglucosamine (GlcNAc); light square, N-acetylgalactosamine; medium dark circle, mannose; dark circle, glucose; light circle, galactose; dark
triangle, fucose; white star, xylose; AA, AA label; LacNAc, Gal1-4GlcNAc1; LewisX, Gal1-4(Fuc1-3)GlcNAc1; LDN, GalNAc1-4GlcNAc1.
Local Antiglycan Responses to Migratory Schistosomula
January 2016 Volume 84 Number 1 iai.asm.org 27Infection and Immunity
 o
n
 February 28, 2017 by UNIVERSITEITSBIBLIO
THEEK
http://iai.asm
.org/
D
ow
nloaded from
 
with nonfucosylated LDN and GlcNAc motifs. In addition, termi-
nal mannose residues and LacNAc and LeX motifs on N- and
O-glycans are targets for IgG in the lung, as well.
Skin LN ASC probe IgM. A total of 39 LC fractions, synthetic
glycoconjugates, and glycoprotein mixtures/isolates showed dif-
ferential IgM binding for the skin LN ASC probes, for which we
observed three clusters (Fig. 2A) with different response patterns
(Fig. 2C). Cluster skin-IgM-C1 showed an increase in antibody
signal intensities in group I5 compared to the control rats, which
only slightly decreased in group I9 (Fig. 2C). The 4 LC fractions
that were included in the cluster consisted of mostly GSL glycans
from eggs and cercariae (3 LC fractions), whereas 3 synthetic gly-
coconjugates were included in the cluster, as well (Fig. 2E). The
GSL glycans all carried fucosylated GalNAc1-4(GlcNAc1)n
stretches (cercarial GSL glycan fractions 18 and 19 and egg GSL
glycan fraction 22.1) (Table 3). Furthermore, one of the synthetic
glycoconjugates found in the cluster was the LDN-F conjugate
(Table 3). Another terminal motif frequently observed in LC frac-
tions within cluster skin-IgM-C1 was the LeX motif, as part of
cercaria-derived GSL glycans and egg-derived O-glycans (cer-
carial GSL glycan fraction 19 and egg O-glycan fraction 36.2) and
as a synthetic glycoconjugate (Table 3). Finally, GlcNAc- and F-
GlcNAc motifs were seen as part of egg-derived O-glycans (egg
O-glycan fraction 36.2) (Table 3).
A total of 9 LC fractions and glycoprotein mixtures/isolates
were found in cluster skin-IgM-C2, which showed enhanced an-
tibody signal intensities in group I5 compared to the control rats.
However, in group I9, signal intensities decreased to intermediate
FIG2 (A and B) Hierarchical-clustering analysis of log2-transformed median fluorescence intensities with background subtracted, classifying the antiglycan IgM
responses in skin LN (A) and lung LN (B) into three and one major cluster(s), respectively. (C and D) Fluorescence intensity signals were averaged for each cluster
and showed different response profiles for skin LN IgM (C) and for lung LN IgM (D). (E and F) Distribution of glycan origins within each skin LN (E) and lung
LN (F) glycan cluster. C, (synthetic) glycoconjugates; N, N-glycan; O, O-glycan; L, GSL glycan.
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TABLE 3 Glycan fractions identified in the different clusters for IgM responses in the skin LN ASC probesa
a Putative structures and structural elements are proposed using literature-guided interpretations of the glycan compositions obtained by MALDI-TOF MS on the basis of the
references listed. C, cluster; fr., fraction; ref., references; Man, terminal mannose(s); core fuc, core fucosylation; core xyl, core xylosylation; X, xylose; F, fucose; H, hexose; N,
N-acetylhexosamine; dark square, N-acetylglucosamine (GlcNAc); light square, N-acetylgalactosamine; medium dark circle, mannose; dark circle, glucose; light circle,
galactose; dark triangle, fucose; white star, xylose; AA, AA label; LacNAc, Gal1-4GlcNAc1; LewisX, Gal1-4(Fuc1-3)GlcNAc1; LDN, GalNAc1-4GlcNAc1.
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levels compared to group I5, although they were still enhanced
compared to the control rats (Fig. 2C). GSL glycans derived from
eggs and cercariae predominated in this cluster (Fig. 2E) and con-
tained structures with DF-LDN-DF (cercarial GSL glycan fraction
21 and egg GSL glycan fraction 23.1), LeX (cercarial GSL glycan
fraction 21), or pseudo-LeY (cercarial GSL glycan fraction 27)
motifs. Because the responses observed in skin IgM clusters C1
and C2 showed the highest intensities in group I5 and again de-
creased in group I9, these responses nicely reflect the migratory
pathway of the schistosomula.
Cluster skin-IgM-C3 did not show changes in signal intensity
for group I5 compared to the control rats, but signal intensities
increased in group I9 (Fig. 2C). This cluster contained 20 LC frac-
tions, approximately 38% of which were cercarial N-glycans. N-
and O-glycans of both adult worms and eggs were also found
within the cluster (Fig. 2E). The glycan structures present in clus-
ter skin-IgM-C3 showed numerous different terminal glycan mo-
tifs on different types of glycans (Table 3). Among the most prom-
inently represented glycan motifs were terminal mannose residues
(cercarial N-glycan fractions 15, 19, and 22; worm N-glycan frac-
tions 1.2 and 6.3; and egg N-glycan fraction 17) and LacNAc (cer-
carial N-glycan fractions 22, 24, and 24.6 and worm O-glycan
fraction 16) and LeX (cercarial N-glycan fraction 27, cercarial GSL
glycan fraction 16, worm O-glycan fraction 16, and egg O-glycan
fraction 16) termini (Table 3). Also terminal GlcNAc (cercarial
N-glycan fractions 19, 20, and 24; worm N-glycan fraction 8; and
worm O-glycan fraction 16) and LDN (cercarial N-glycan fraction
20, cercarial GSL glycan fraction 16, and worm O-glycan fraction
16) motifs were observed, some of which were more abundantly
fucosylated (cercarial GSL glycan fraction 16 and egg O-glycan
fraction 16) (Table 3). These glycan structures thus show great
similarity (but are not completely identical) to the terminal motifs
observed in skin IgG response clusters C1 and C2 (Table 1); how-
ever, the IgM antibodies recognizing these motifs are induced at a
later stage (Fig. 1C and 2C), when the schistosomula have already
migrated out of the skin.
Taken together, the IgM responses of the skin LN ASC probes
thus target fucosylated GalNAc1-4(GlcNAc1)n stretches on
GSL glycans 5 days after secondary infection, at the expected peak
in antibody production, possibly together with specific O- and
GSL glycans expressing LeX and (fucosylated) GlcNAc motifs.
IgM responses targeting terminal mannose residues and LeX and
LacNAc motifs were observed only after the schistosomula had
already migrated out of the skin.
Lung LN ASC probe IgM. Only 4 LC fractions were differen-
tially recognized by the IgM responses of the lung LN ASC probes.
One cluster of 3 LC fractions was observed (Fig. 2B). The IgM
antibodies within this lung-IgM-C1 cluster gave only slightly in-
creased signal intensities in group I5 compared to the control
group, whereas for group I9, signal intensities were far higher than
in the control group (Fig. 2D). All LC fractions found in the cluster
were composed of N-glycans derived from adult worms (Fig. 2F).
Most of the glycan structures within these LC fractions presented
terminal LDN motifs (worm N-glycan fractions 9.2 and 10), but
LacNAc motifs (worm N-glycan fraction 9.2) and terminal man-
nose residues (worm N-glycan fraction 8.5) were detected, as well
(Table 4). These observations further underline the fact that N-
glycans with LDN and GN motifs that are expressed by the schis-
tosomula can be targets for antibody responses when the schisto-
somula pass through the lungs.
DISCUSSION
Our data show that antiglycan antibody responses in skin and lung
LN ASC probes of S. japonicum-infected rats peaked at the time
points (5 days and 9 days, respectively) reflecting the migration of
the invading larvae. Using an elaborate microarray constructed of
naturally occurring glycans isolated from schistosomes, we were
able to confirm that in the lung LN ASC probes, antibody re-
sponses were mainly directed against N-glycans with terminal
GlcNAc, LeX, and LacNAc motifs and terminal mannose residues,
as was shown by McWilliam et al. using a glycan array with syn-
thetic glycan structures (10). In addition, we found that LDN mo-
tifs present on N-glycans were also recognized by IgG and IgM
produced by lung LN ASC probes. Furthermore, by defining the
different response patterns, we revealed that antibodies to N-gly-
cans with LDN motifs and terminal GlcNAc and mannose resi-
dues were detected in the lung LN ASC probes in significant
amounts only at 9 days postinfection, corresponding to the pas-
sage of schistosomula through the lung vasculature around that
time point. In addition to the antiglycan responses in the lung, in
this study, we also addressed the glycan structures recognized by
responses in the skin LN ASC probes. For these ASC probes, we
showed that antibody responses were mostly targeted at N-glycans
with terminal mannose residues and LacNAc, LeX, GlcNAc, and
LDN motifs and at GSL glycans with fucosylated GalNAc1-
4(GlcNAc1)n stretches. Antibody levels either peaked at 5
days postinfection and were sustained or were induced in later
infection stages. Responses to the fucosylated GalNAc1-
TABLE 4 Glycan fractions identified in cluster C1 for IgM responses in the lung LN ASC probesa
a Putative structures and structural elements are proposed using literature-guided interpretations of the glycan compositions obtained by MALDI-TOF MS on the basis of the
references listed. C, cluster; fr., fraction; ref., references; Man, terminal mannose(s); core fuc, core fucosylation; core xyl, core xylosylation; X, xylose; F, fucose; H, hexose; N, N-
acetylhexosamine; dark square, N-acetylglucosamine (GlcNAc); light square, N-acetylgalactosamine; medium dark circle, mannose; dark circle, glucose; light circle, galactose; dark
triangle, fucose; white star, xylose; AA, AA label; LacNAc, Gal1-4GlcNAc1; LewisX, Gal1-4(Fuc1-3)GlcNAc1; LDN, GalNAc14GlcNAc1.
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4(GlcNAc1)n stretches present on GSL glycans were exclusively
found among those clusters showing sustained high antibody
binding levels up to 9 days postinfection. The sustained binding of
antibodies to all of these different glycans in the skin LN ASC
probes might indicate that at least some of the glycans can still be
found in the skin after the schistosomula have already migrated
toward the lungs.
Interestingly, antibodies produced by the skin LN ASC probes
bound only to the surfaces of cercariae and not to 24-h schistoso-
mula (10). A possible explanation would be the relatively fast mi-
gration through the skin and subsequently to the lungs by S. ja-
ponicum, in combination with a change in surface-exposed
antigens after transformation, thereby preventing the develop-
ment of antibodies to schistosomula (43). Cercarial secretions and
parts of the cercarial glycocalyx remain in the skin for a longer
time, allowing the immune system to develop local antibody re-
sponses to antigenic motifs present in these schistosome-derived
products. Cercarial secretions contain many LacNAc and LeX el-
ements in both the N- and O-glycans (24). In the glycan microar-
ray analysis, we observed a reaction against these types of glycans
by skin LN ASC probes. In particular, the clusters skin-IgG-C1,
skin-IgG-C2, and skin-IgM-C1 showed prolonged antibody re-
sponse profiles that might be associated with the presence of se-
cretions or material shed into the skin by penetrating cercariae or
developing schistosomula, rather than with surface-exposed
structures. For S. mansoni, it was shown that skin stage schistoso-
mula still express glycocalyx-related antigens and leave traces in
the skin upon further migration to the lungs (43–46) and that
O-glycans expressed by the glycocalyx are quite abundant and
antigenic (20, 35). However, we observed no significant binding of
IgG or IgM from skin ASC probes to the glycocalyx-associated
O-glycans that were on the glycan microarray. This might suggest
that the expression level of these O-glycan types is absent or too
low to mount an antibody response or that antibody responses are
induced at a later time point. Alternatively, differences in the O-
glycan structures between S. japonicum and S. mansoni might be a
reason for the absence of responses to O-glycans on the microar-
ray, since we studied the antiglycan responses raised to S. japoni-
cum by making use of a shotgun glycan microarray containing
glycans derived from S. mansoni. Glycosylations in both species
are highly similar based on the limited literature available (22, 36,
37). The few differences that have been identified are related to
glycan structures that are lacking in S. japonicum compared to S.
mansoni (36, 37). Given this high resemblance and in view of the
big investment needed to make an S. japonicum-specific array to
add perhaps just a few (if any) S. japonicum-specific glycans, we
decided to use the previously generated S. mansoni glycan mi-
croarray to study antiglycan antibodies induced in S. japonicum-
infected rats. However, some differences that have to be consid-
ered when interpreting our array data have been described, as well.
First, core xylosylation is absent from the N-glycans of S. japoni-
cum cercariae, making it likely that the same will be true for schis-
tosomula (22). Antibodies to the xylosylated N-glycans, as ob-
served in sera of schistosome-infected humans and animals,
would logically be absent in the ASC probes studied. Furthermore,
multifucosylated terminal structures expressed in all life stages of
S. mansoni (9, 20, 21, 24, 25, 36, 41) and highly antigenic in S.
mansoni infection (47–49) were not detected on protein- or lipid-
linked glycans from eggs of S. japonicum (36, 37). Whether such
multifucosylated terminal motifs, including DF motifs, are pres-
ent or absent in other life stages of S. japonicum needs further
research. If DF elements are not expressed by S. japonicum larvae,
this would be a possible explanation for the relatively low number
of multifucosylated O-glycan structures bound by the skin LN
ASC probes. However, some of the GSL glycans that contained
many fucoses were bound by IgM and IgG in skin LN ASC probes,
suggesting that S. japonicum cercariae and/or schistosomula do
express this type of GSL glycan structure or similar terminal gly-
can motifs. Besides differences in expression profiles, the localiza-
tion of these glycans might also be different across different spe-
cies, indicating that it would be worthwhile to investigate the
structures and localization of glycans expressed by S. japonicum
schistosomula and other life stages.
In the lung LN ASC probes, we observed intense antibody
binding to LDN and GlcNAc motifs. LDN motifs appear to be
surface expressed throughout worm development (19, 49), but
LDN expression becomes more abundant on N-glycans when the
worms mature, while LDN expression by other types of glycans,
especially in later stages of development, including lung stage
schistosomula, is hardly present (9). Together with the previously
observed binding of lung LN ASC probes to the surface of the
developing schistosomula, this indicates that these antibodies
were raised against surface-exposed antigens, including N-glycans
with LDN motifs (10). Responses to N-glycans displaying LacNAc
and LeX motifs were also observed for the lung LN ASC probes.
For S.mansoni, it has been shown that these motifs are still present
in schistosomula up to several days after transformation, espe-
cially in the N-glycan pool (9), and LeX motifs were also shown to
be surface exposed on schistosomula (28). Given the high resem-
blance of cercarial N-glycans (22) and the expression and antige-
nicity of LeX (50) between S. mansoni and S. japonicum, it is likely
that schistosomula of S. japonicum also surface expose these mo-
tifs.
Strikingly, in the lung LN ASC probes, we observed no signif-
icant IgG or IgM reaction to the GSL glycans, whereas these gly-
cans with their highly fucosylated GalNAc1-4(GlcNAc1)n
stretches were bound by antibodies present in the skin LN ASC
probes. For S. mansoni, it has been shown previously that multi-
fucosylated GSL glycans remained expressed in later stages of
schistosomula development (9) and are surface exposed (28), and
they have been shown to be major targets of antibody response in
sera of infected individuals (47–49, 51). The reason we did not
observe significant binding for lung LN ASC probes might be the
differences in the expression of these glycans between S. mansoni
and S. japonicum. Since S. japonicum does not express multifuco-
sylated motifs in the egg stages (36, 37), it is possible that multi-
fucosylated motifs are shed by S. japonicum cercariae or schisto-
somula in the skin and are not further expressed in subsequent
stages. There might be a gradual change during maturation, so
that multifucosylated LDN motifs have already been replaced by
other (less antigenic) structures when the schistosomula reach the
lungs. For S. mansoni, it was determined that protein-linked mul-
tifucosylated glycans disappear from the schistosomula glycome
after 3 days, whereas GSL-linked DF elements remain in the over-
all spectrum, as well as exposed at the surface (9, 28). If these
expression patterns are similar for S. japonicum, an alternative
explanation for the absence of reactivity in the lung could be the
differential expression on protein and lipid carriers. Little is
known about the mechanisms by which antibodies to protein-
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linked glycans are generated, and knowledge about how anti-GSL
glycan antibodies are induced is even more negligible.
Through the combined use of ASC probes and shotgun glycan
microarrays, we identified the antiglycan responses raised against
migrating schistosomula in rats. These local recognition profiles
are broad, given the variety of glycans expressed by Schistosoma
(9). Our data indicate that N-glycans with terminal mannose res-
idues, LacNAc motifs, and LeX motifs, abundantly present in se-
cretions of cercariae and schistosomula, together with GSL gly-
cans containing fucosylated LDN and GlcNAc motifs, were major
targets of antibody responses raised in the skin LN ASC probes.
Antibodies raised in the lung LN ASC probes were mainly directed
toward N-glycans presenting LDN and GlcNAc motifs, most likely
present at the surfaces of the migrating schistosomula. Since an-
tibody-dependent mechanisms primarily mediate resistance to
infection in rats (12), each of the glycans recognized by these local
immune responses possibly plays a role in elimination of the par-
asite. Given the breadth of the recognition profile, it is impossible
to define individual glycan structures that might be involved in
protection. Antibodies raised against glycans are specific for cer-
tain glycan elements but might not be functional in inducing pro-
tection. In addition, some of the glycan structures and glycan ele-
ments recognized might also be expressed by the host and are
therefore not considered good vaccine candidates. Since the ex-
pression of glycans and antibodies raised against these glycans is so
broad, it might also be worthwhile testing whether this polyvalent
expression plays a role in generating protective immune re-
sponses. Future studies are therefore needed to further investigate
the specific roles of antigenic glycans and glycan elements in the
parasite-host interaction and to explore the possible role of anti-
bodies against parasite glycan motifs in antibody-mediated pro-
tection against S. japonicum infection.
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